Drugs / Bacillus Calmette-Guérin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05507671 Comparator | May 2021 → Jul 2023 overdue | COVID-19 | Oswaldo Cruz Foundation | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus Calmette-Guérin | “BCG (Bacillus Calmette-Guérin) vaccine” NCT05507671 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05507671 ↗ |
| Modality | Vaccine | “BCG vaccine” NCT05507671 ↗ |